In contrast, the survival and lung tumor progression of KL9 mice after tumor induction were not affected by API treatment (Figure 6A–C), indicating IL‐36γ as a primary target of API in the KL NSCLC model. This evidence concerns the gene IL36G and non-small cell lung carcinoma.